Inflammatory myopathies: Part 2.
Mastaglia
F L
FL
Ojeda
V J
VJ
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000974:Antibodies, Antinuclear / Q000032:analysis; D003586:Cytomegalovirus Infections / Q000473:pathology; D003882:Dermatomyositis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000628:therapy; D004802:Eosinophilia / Q000473:pathology; D006099:Granuloma / Q000473:pathology; D006801:Humans; D009220:Myositis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000473:pathology / Q000628:therapy; D009886:Ophthalmoplegia / Q000209:etiology / Q000473:pathology; D009915:Orbit / Q000473:pathology; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use; D014777:Virus Diseases / Q000150:complications
D000305:Adrenal Cortex Hormones; D000974:Antibodies, Antinuclear; D011241:Prednisone